Neurosense Therapeutics LTD. (NRSN) — 6-K Filings
All 6-K filings from Neurosense Therapeutics LTD.. Browse 4 Foreign Current Report reports with AI-powered summaries and risk analysis.
6-K Filings (4)
-
NeuroSense Therapeutics Files 6-K Report
— Apr 6, 2026 Risk: low
NeuroSense Therapeutics Ltd. filed a Form 6-K on April 6, 2026, reporting as a foreign private issuer. The filing includes a press release dated April 6, 2026, - 6-K Filing — Apr 3, 2026
-
NeuroSense Therapeutics Files 6-K Report
— Mar 31, 2026 Risk: low
NeuroSense Therapeutics Ltd. filed a Form 6-K on March 31, 2026, reporting its status as a foreign private issuer. The filing includes a press release dated Mar -
NeuroSense Files Routine 6-K with March 24, 2026 Press Release
— Mar 24, 2026
NeuroSense Therapeutics Ltd. filed a 6-K on March 24, 2026, which included a press release dated the same day. This filing, identified by SEC Accession No. 0001
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX